FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


15270 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Buprenorphine hydrochloride + naloxone hydrochloride Product containing buprenorphine and naloxone (medicinal product)
buprenorfinhydroklorid 2 mg + naloxonhydroklorid 0,5 mg, resoriblett Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet
buprenorfinhydroklorid 8 mg + naloxonhydroklorid 2 mg, resoriblett Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet
bupropionhydroklorid 100 mg, tablett med modifierad frisättning Product containing only bupropion in oral dose form (medicinal product form)
bupropionhydroklorid 100 mg, depåtablett Product containing only bupropion in oral dose form (medicinal product form)
bupropionhydroklorid 200 mg, tablett med modifierad frisättning Product containing only bupropion in oral dose form (medicinal product form)
bupropionhydroklorid 200 mg, depåtablett Product containing only bupropion in oral dose form (medicinal product form)
bupropionhydroklorid 300 mg, tablett med modifierad frisättning Product containing only bupropion in oral dose form (medicinal product form)
bupropionhydroklorid 300 mg, depåtablett Product containing only bupropion in oral dose form (medicinal product form)
bupropionhydroklorid 50 mg, tablett med modifierad frisättning Product containing only bupropion in oral dose form (medicinal product form)
bupropionhydroklorid 50 mg, depåtablett Product containing only bupropion in oral dose form (medicinal product form)
Burkholderia Genus Burkholderia (organism)
Burkholderia cocovenenans Burkholderia gladioli
Burkholderia vandii Burkholderia plantarii
Burkitts lymfom i lymfknutor i axill och arm Burkitt lymphoma of lymph nodes of upper limb (disorder)
Burkitts lymfom i lymfknutor i inguinalregion och ben Burkitt lymphoma of lymph nodes of lower limb (disorder)
Burkitts tumör, extranodal och/eller organlokaliserad Burkitt's lymphoma (clinical)
Burkitts lymfom i lymfknutor i axill och/eller arm Burkitt lymphoma of lymph nodes of upper limb (disorder)
Burkitts lymfom i lymfknutor i inguinalregion och/eller ben Burkitt lymphoma of lymph nodes of lower limb (disorder)
brännskada som engagerar 10-14 procent av kroppsytan, varvid 10-14 procent av kroppsytan är fullhudsbrännskadad Burn involving 10-19 percent of body surface, with 10-14 percent of body surface with full thickness burn (disorder)
brännskada som engagerar 15-19 procent av kroppsytan, varvid 10-19 procent av kroppsytan är fullhudsbrännskadad Burn involving 10-19 percent of body surface, with 15-19 percent of body surface with full thickness burn (disorder)
Burn of larynx, trachea AND/OR lung Burn
Burn of other internal organ, NEC Burn of internal organ
Burn to cornea - erythema Corneal burn
Burn to cornea - erythema Corneal burn
buserelin 150 mikrogram, sprej Buserelin only product
Buspirone hydrochloride 5mg tablet Buspirone hydrochloride 5 mg oral tablet
Buspirone hydrochlorine Buspirone hydrochloride (substance)
butabarbitalnatrium 30 mg/5 ml, elixir Product containing precisely secbutabarbital sodium 6 milligram/1 milliliter conventional release oral solution (clinical drug)
butorfanoltartrat 1 mg/ml, injektionsvätska, lösning, ampull Butorphanol tartrate 1 mg/mL solution for injection
butorfanoltartrat 2 mg/ml, injektionsvätska, lösning, ampull Butorphanol only product in parenteral dose form
icke kärlsäkrad skinklambå Random pattern flap
toxisk effekt av knappbatteri Toxic effect of sulfuric acid
butylnitrat, icke läkemedel Butyl nitrate
antipsykotiskt medel innehållande butyrofenonderivat Butyrophenone derivative
Butyrophenone poisoning NOS Poisoning by butyrophenone-based tranquilizer
Bypass of organ NOC Construction of shunt
behandling med Byrds respirator Respiratory therapy
C/O - specified symptom findings Finding reported by subject or history provider (finding)
C1-esterashämmare 500 enheter, pulver till injektionsvätska, lösning, injektionsflaska 8 ml Product containing precisely human C1 esterase inhibitor 500 unit/1 vial powder for conventional release solution for injection (clinical drug)
CDC Corynebacterium group G-1 Corynebacterium accolens
CDC group DF-2 Capnocytophaga canimorsus
CDE genotype CDE haplotype (finding)
CDe genotype CDe haplotype (finding)
CTV3 ROOT SNOMED CT Concept
kål, livsmedel Cabbage (substance)
Cabergoline [parkinsons] Product containing cabergoline (medicinal product)
Caesarean delivery - delivered Deliveries by caesarean
Caffeine and sodium benzoate injection Product containing caffeine and sodium benzoate (medicinal product)
koffeininnehållande substans, icke läkemedel Caffeine
café-au-lait-fläckar och ringkromosom 11 Ring chromosome 11 syndrome
kalcipotrien 0,005 %/betametason 0,064 %, suspension för lokalt bruk Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and calcipotriol 50 microgram/1 milliliter conventional release cutaneous lotion (clinical drug)
kalcitonin från lax 100 enheter/ml, injektionsvätska, lösning, flaska 1 ml Product containing precisely salmon calcitonin 100 unit/1 milliliter conventional release solution for injection (clinical drug)
laxkalcitonin 200 IE/ml, sprej Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug)
Calcitonin, salmon 200unt/mL injection Salmon calcitonin 200 unit/mL solution for injection
kalcitonin från lax 200 enheter/ml, injektionsvätska, lösning, flaska 2 ml Salmon calcitonin 200 unit/mL solution for injection
Calcium analyte Calcium
kalciumbaserat antacidum Calcium compound
kalciumkarbonat 1,25 g + kolekalciferol 11 mikrogram, dospåse med granulat Calcium carbonate 6.25 mg/mL and colecalciferol 2.2 unit/mL oral solution
kalciumklorid 10 %, injektionsvätska, lösning, förfylld spruta 10 ml Product containing precisely calcium chloride 100 milligram/1 milliliter conventional release solution for injection (clinical drug)
kalciumhydroxiapatit, mikrosfärsuspension i vattenbaserad bärare, förfylld spruta 0,3 ml Hydroxyapatite only product in parenteral dose form
kalciumhydroxiapatit, mikrosfärsuspension i vattenbaserad bärare, förfylld spruta 1,3 ml Hydroxyapatite only product in parenteral dose form
kalciumfosfat 3 100 mg + cholekalciferol 20 mikrogram per dospåse, pulver till oral suspension Calcium phosphate and colecalciferol only product
Calculus - composition Calculus chemical composition - finding
Calculus exam. general Calculus examination
Calculus examination NOS Calculus examination
Calculus examination NOS Calculus examination
allmän undersökning av sten Calculus examination
Calculus gen. exam. NOS Calculus examination
Calculus general examination NOS Calculus examination
kalfaktant, intratraekal suspension, flaska 6 ml Product containing only calfactant (medicinal product)
Calicivirus group Family Caliciviridae (organism)
Calliphora erythrocephala Calliphora vicina
Callitrogae Genus Cochliomyia (organism)
Caloric intake, function (observable entity) Energy intake (observable entity)
Caloscypha fulgens Caloscypha fulgens (organism)
Calymmatobacterium granulomatis Klebsiella granulomatis (organism)
biverkning av kamouflerande preparat Adverse reaction (disorder)
Campylobacter cinaedi Helicobacter cinaedi
Campylobacter fennelliae Helicobacter fennelliae
Campylobacter laridis Campylobacter lari
Campylobacter laridis rRNA Campylobacter lari rRNA
Campylobacter laridis rRNA assay Campylobacter lari rRNA assay
Campylobacter nitrofigilis Arcobacter nitrofigilis (organism)
kanakinumab 150 mg, pulver till injektionsvätska, lösning Canakinumab only product
cancervårdplan Cancer care plan
Cancer care plan Cancer care plan
Cancer care plan Cancer care plan
genomgång av cancerbehandling Cancer care review (procedure)
utförd screening för livmoderhalscancer Screening for malignant neoplasm of cervix done (situation)
Candida famata Debaryomyces hansenii
Candida famata Debaryomyces hansenii
Candida guilliermondii, varietet guilliermondii Meyerozyma guilliermondii (organism)
Candida humicola Vanrija humicola (organism)
Candida krusei var. vanlaeriana Pichia membranifaciens (organism)
Candida lipolytica Yarrowia lipolytica
Candida pseudotropicalis Kluyveromyces marxianus
Candidiasis of other specified sites Candidiasis
Candidiasis of other urogenital sites Candidiasis of urogenital site
Canine cortical hyperostosis Disorder of bone (disorder)
Canis familiaris Canis lupus subspecies familiaris (organism)

Start Previous Page 18 of 153 Next End


Reference Sets

Reference set descriptor

GB English

US English

Back to Start